» Articles » PMID: 20576578

Ortho-Substituted C-aryl Glucosides As Highly Potent and Selective Renal Sodium-dependent Glucose Co-transporter 2 (SGLT2) Inhibitors

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2010 Jun 26
PMID 20576578
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A series of 2-substituted C-aryl glucosides have been synthesized and evaluated for inhibition of hSGLT1 and hSGLT2. Introduction of an appropriate ortho substituent at the proximal phenyl ring adjacent to the glycosidic bond was found to improve SGLT2 inhibitory activity and dramatically increase selectivity for hSGLT2 over hSGLT1. Selected compounds were investigated for in vivo efficacy.

Citing Articles

Design, synthesis and biological evaluation of non-glucosidal based 1,3,4-thiadiazoles as SGLT-2 inhibitors.

Sharma S, Kumar S, Gupta J, Mittal A, Khurana N Future Med Chem. 2025; 17(4):409-423.

PMID: 39935011 PMC: 11834423. DOI: 10.1080/17568919.2025.2463869.


Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives.

Maccari R, Ottana R J Med Chem. 2022; 65(16):10848-10881.

PMID: 35924548 PMC: 9937539. DOI: 10.1021/acs.jmedchem.2c00867.


SGLT inhibitors as antidiabetic agents: a comprehensive review.

Kshirsagar R, Kulkarni A, Chouthe R, Pathan S, Une H, Reddy G RSC Adv. 2022; 10(3):1733-1756.

PMID: 35494673 PMC: 9048284. DOI: 10.1039/c9ra08706k.


A specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

Tang C, Zhu X, Huang D, Zan X, Yang B, Li Y J Mol Model. 2011; 18(6):2795-804.

PMID: 22120948 DOI: 10.1007/s00894-011-1303-1.